What one small trial does and does not show
A randomised study involving 40 people with diabetic foot ulcers evaluated Bioptron alongside standard wound care. A single small study cannot establish effectiveness for all wound types, and it does not make light therapy a substitute for wound assessment, infection management or off-loading where indicated.
Diabetes-related wounds, spreading redness, fever, increasing pain or discharge need prompt professional attention. Ask the treating clinician before adding any device-based treatment to a wound-care plan.
Source consulted: Randomised Bioptron trial for diabetic foot ulcers, PubMed.
Explore Bioptron Hyperlight Therapy.svg)
.svg)
